U.S. FDA Vaccine Review Meeting Scheduled for December 10, 2020

The U.S. FDA posted online background material for the upcoming Vaccines and Related Biological Products Advisory Committee (VRBPAC) public meeting, scheduled for Thursday, December 10, 2020.

This VRBPAC digital meeting will discuss Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) for the prevention of COVID-19 in individuals 16 years of age and older.

Following this meeting, the U.S. CDC's vaccine committee has scheduled an emergency review of the FDA's recommendations on December 11th and 13th, then vote on their recommendation.